Add like
Add dislike
Add to saved papers

Detection of acute coronary occlusion in patients with acute coronary syndromes presenting with isolated ST-segment depression.

OBJECTIVES: This study sought to determine whether 80-lead body surface potential mapping (BSPM) would improve detection of acute myocardial infarction (AMI) and occluded culprit artery in patients presenting with ST-segment depression (STD) only on 12-lead ECG.

BACKGROUND: In patients with acute coronary syndromes (ACS), the standard 12-lead ECG has limited sensitivity (50-60%) for AMI.

METHODS: Consecutive patients presenting pre- and in-hospital between 2000 and 2006 with acute ischaemic-type chest pain and an initial 12-lead ECG with STD only of ≥ 0.05 mV in two or more contiguous leads were analysed. Flow in the culprit artery at angiography was graded using the TIMI flow grade (TFG) criteria.

RESULTS: Enrolled were 410 patients: of these, 240 (59%) had an occluded culprit artery (TFG 0/1) with AMI, 80 (19%) had a patent culprit artery (TFG 2/3) with AMI, 67 (16%) had TFG 2/3 with cardiac troponin T (cTnT) <0.03 µg/l, and 23 (6%) had TFG 0/1 with cTnT < 0.03 µg/l. BSPM ST-segment elevation (STE) occurred in 267 (65%) patients. For the diagnosis of TFG 0/1 in the culprit artery and AMI, BSPM STE had sensitivity 91% and specificity 72% with STE occurring most commonly in the posterior territory (60%). Patients with TFG 0/1 and AMI were significantly more likely to suffer death or nonfatal MI at 30 days than those with TFG 2/3 and cTnT < 0.03 µg/l (adjusted hazard ratio 4.12, 95% CI 1.67-8.56, p = 0.003).

CONCLUSION: Among 410 ACS patients presenting with only STD, BSPM identifies STE beyond the territory of the 12-lead ECG with sensitivity 91% and specificity 72% for diagnosis of occluded culprit artery with AMI.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app